EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Majchrzak, M; Celiński, R. Cathinone derivatives and their analysis. In Chromatographic Techniques in the Forensic Analysis of Designer Drugs; Kowalska, T; Sajewicz, M; Sherma, J, Eds., CRC Press, Taylor & Francis Group, 1 Jan 2018; pp 251–276. 1.1 MB.
Kraemer, M; Boehmer, A; Madea, B; Maas, A. Death cases involving certain new psychoactive substances: A review of the literature. Forensic Sci. Int., 1 May 2019, 298, 186–267. 6.7 MB. https://doi.org/10.1016/j.forsciint.2019.02.021 #PV9
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. A method for identifying designer drugs of synthetic cathinones. JCCL, 1 Dec 2015, (55), 17–41. 663 kB. #30 Japanese, English abstract MS,NMR,IR,UV
Uchiyama, N; Matsuda, S; Kawamura, M; Shimokawa, Y; Kikura-Hanajiri, R; Aritake, K; Urade, Y; Goda, Y. Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products. Forensic Sci. Int., 1 Oct 2014, 243, 1–13. 742 kB. https://doi.org/10.1016/j.forsciint.2014.03.013 #7, POP GC,LC,MS,NMR,UV
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV. J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #V6 LC
Morikawa, Y; Miyazono, H; Sakai, Y; Suenami, K; Sasajima, Y; Sato, K; Takekoshi, Y; Monguchi, Y; Ikari, A; Matsunaga, T. 4‘-Fluoropyrrolidinononanophenone elicits neuronal cell apoptosis through elevating production of reactive oxygen and nitrogen species. Forensic Toxicol., 1 Jan 2021, 39 (1), 123–133. 1.4 MB. https://doi.org/10.1007/s11419-020-00550-x #α-POP MS,NMR